These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7621092)

  • 1. Pharmacology of neuromuscular blockade: interactions and implications for concurrent drug therapies.
    Dickens MD
    Crit Care Nurs Q; 1995 Aug; 18(2):1-12. PubMed ID: 7621092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current therapeutic uses, pharmacology, and clinical considerations of neuromuscular blocking agents for critically ill adults.
    Warr J; Thiboutot Z; Rose L; Mehta S; Burry LD
    Ann Pharmacother; 2011 Sep; 45(9):1116-26. PubMed ID: 21828347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromuscular Blockade in the 21st Century Management of the Critically Ill Patient.
    deBacker J; Hart N; Fan E
    Chest; 2017 Mar; 151(3):697-706. PubMed ID: 27818334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applied pharmacology of common neuromuscular blocking agents in critical care.
    Prielipp RC; Coursin DB
    New Horiz; 1994 Feb; 2(1):34-47. PubMed ID: 7922428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacoeconomic issues of sedation, analgesia, and neuromuscular blockade in critical care.
    Armstrong DK; Crisp CB
    New Horiz; 1994 Feb; 2(1):85-93. PubMed ID: 7922434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiopulmonary implications of neuromuscular blockade.
    Sandmeyer NP; Ashworth LJ
    Crit Care Nurs Q; 1995 Aug; 18(2):25-40. PubMed ID: 7621094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of Continuous Infusion Neuromuscular Blocking Agents in the Adult Intensive Care Unit.
    Smetana KS; Roe NA; Doepker BA; Jones GM
    Crit Care Nurs Q; 2017; 40(4):323-343. PubMed ID: 28834856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous-infusion neuromuscular blocking agents in critically ill neonates and children.
    Johnson PN; Miller J; Gormley AK
    Pharmacotherapy; 2011 Jun; 31(6):609-20. PubMed ID: 21923445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of sedation and neuromuscular paralysis during mechanical ventilation.
    Halloran T
    Crit Care Nurs Clin North Am; 1991 Dec; 3(4):651-7. PubMed ID: 1777201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Paralysis for the Management of ARDS.
    Grawe ES; Bennett S; Hurford WE
    Respir Care; 2016 Jun; 61(6):830-8. PubMed ID: 27094392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromuscular blockade management in the critically Ill patient.
    Renew JR; Ratzlaff R; Hernandez-Torres V; Brull SJ; Prielipp RC
    J Intensive Care; 2020; 8():37. PubMed ID: 32483489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromuscular blocking agents in critical care.
    Susla GM
    Crit Care Nurs Clin North Am; 1993 Jun; 5(2):297-311. PubMed ID: 8398037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual neuromuscular blockade in critical care.
    Wilson J; Collins AS; Rowan BO
    Crit Care Nurse; 2012 Jun; 32(3):e1-9; quiz e10. PubMed ID: 22661165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When should sedation or neuromuscular blockade be used during mechanical ventilation?
    Bennett S; Hurford WE
    Respir Care; 2011 Feb; 56(2):168-76; discussion 176-80. PubMed ID: 21333177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive Care Nurses' Knowledge About Use of Neuromuscular Blocking Agents in Patients With Respiratory Failure.
    Frazee EN; Personett HA; Bauer SR; Dzierba AL; Stollings JL; Ryder LP; Elmer JL; Caples SM; Daniels CE
    Am J Crit Care; 2015 Sep; 24(5):431-9. PubMed ID: 26330436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceived safety and efficacy of neuromuscular blockers for acute respiratory distress syndrome among medical intensive care unit practitioners: A multicenter survey.
    Torbic H; Bauer SR; Personett HA; Dzierba AL; Stollings JL; Ryder LP; Daniels CE; Caples SM; Frazee EN
    J Crit Care; 2017 Apr; 38():278-283. PubMed ID: 28012426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of cisatracurium (51W89) and atracurium by infusion in critically ill patients.
    Newman PJ; Quinn AC; Grounds RM; Hunter JM; Boyd AH; Eastwood NB; Pollard BJ; Pearson AJ; Harper NJ; Beale RJ; Sutjarittam M; Elliot JM; Bion JF
    Crit Care Med; 1997 Jul; 25(7):1139-42. PubMed ID: 9233738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromuscular blockade: indications, peripheral nerve stimulation, and other concurrent interventions.
    Davidson JE
    New Horiz; 1994 Feb; 2(1):75-84. PubMed ID: 7922432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An algorithm for train-of-four monitoring in patients receiving continuous neuromuscular blocking agents.
    Jones SK
    Dimens Crit Care Nurs; 2003; 22(2):50-7; quiz 58-9. PubMed ID: 12649615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep in critically ill chemically paralyzed patients requiring mechanical ventilation.
    Hardin KA; Seyal M; Stewart T; Bonekat HW
    Chest; 2006 Jun; 129(6):1468-77. PubMed ID: 16778263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.